| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702143 | Practical Radiation Oncology | 2017 | 26 Pages |
Abstract
RM was associated with decreased use of LC boost without significant differences in acute toxicities. Further investigation to delineate LCs in patients undergoing RM or identify alternative strategies for delivering LC dose is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jolinta Y. MD, Rachel MD, Enid MD, PhD, Sally MD, Elizabeth M. MD, Randi J. MD, MS, Soren M. DSc, PhD, Cynthia MD, Susan MD, Emily MD, Paula MD, Katherine MD, Sheri MD, Steven J. MD,